Security key
77313F106
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,265,652
- Total 13F shares
- 91,180,049
- Share change
- -5,128,237
- Total reported value
- $320,068,446
- Price per share
- $3.51
- Number of holders
- 183
- Value change
- -$17,903,135
- Number of buys
- 88
- Number of sells
- 89
Report period
Q4 2025
Institutions
183
Top holders
10
RCKT full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
ROCKET PHARMACEUTICALS, INC. SEC filings
ROCKET PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 77313F106
Recent filing periods:
Ownership snapshot
Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
Lead holder
MAVERICK CAPITAL LTD
13D/G signal
MAVERICK CAPITAL LTD
Evidence rows
50
Latest as of
30 Sep 2025
13F
13D/G
3/4/5
Lead comparable stake: 2.3%
13D/G row: MAVERICK CAPITAL LTD
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MAVERICK CAPITAL LTD |
13F
13D/G
Company
|
2.3%
from 13D/G
|
$27,606,801
8,468,344 shares
|
— | 30 Sep 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
|
0.9%
|
$7,895,181
1,004,476 shares
|
-$48,317,346 | 30 May 2025 |
| Roderick Wong |
3/4/5
Director, 10%+ Owner
|
17%
|
$44,689,444
18,236,124 shares
|
— | 18 Jun 2025 |
| David P. Southwell |
3/4/5
Director
|
0.13%
|
$354,806
144,784 shares
|
— | 18 Jun 2025 |
| Pedro P. Granadillo |
3/4/5
Director
|
0.05%
|
$134,131
54,734 shares
|
— | 18 Jun 2025 |
| Peter Fong |
3/4/5
Director
|
0.05%
|
$174,932
53,333 shares
|
— | 24 Sep 2025 |
| Carsten Boess |
3/4/5
Director
|
0.03%
|
$73,518
30,000 shares
|
— | 18 Jun 2025 |
| Fady Ibraham Malik |
3/4/5
Director
|
0.03%
|
$73,518
30,000 shares
|
— | 18 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
6.5%
|
$23,192,850
7,114,371 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
6.3%
|
$22,468,585
6,892,204 shares
|
— | 30 Sep 2025 |
| MPM BioImpact LLC |
13F
Company
|
3.6%
|
$12,725,022
3,903,381 shares
|
— | 30 Sep 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
Company
|
3.5%
|
$12,529,266
3,843,333 shares
|
— | 30 Sep 2025 |
| MORGAN STANLEY |
13F
Company
|
3.3%
|
$11,889,347
3,647,039 shares
|
— | 30 Sep 2025 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
3.3%
|
$11,639,475
3,570,391 shares
|
— | 30 Sep 2025 |
| Monaco Asset Management SAM |
13F
Company
|
2.6%
|
$9,428,771
2,892,261 shares
|
— | 30 Sep 2025 |
| Newtyn Management, LLC |
13F
Company
|
2.3%
|
$8,159,333
2,502,863 shares
|
— | 30 Sep 2025 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
2%
|
$7,138,585
2,189,750 shares
|
— | 30 Sep 2025 |
| JPMORGAN CHASE & CO |
13F
Company
|
1.9%
|
$6,836,329
2,097,033 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.8%
|
$6,242,766
1,914,554 shares
|
— | 30 Sep 2025 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
1.6%
|
$5,854,148
1,795,751 shares
|
— | 30 Sep 2025 |
| STATE STREET CORP |
13F
Company
|
1.6%
|
$5,689,711
1,745,310 shares
|
— | 30 Sep 2025 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
1.5%
|
$5,247,563
1,609,682 shares
|
— | 30 Sep 2025 |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
Company
|
1.2%
|
$4,282,783
1,313,737 shares
|
— | 30 Sep 2025 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
1.2%
|
$4,143,763
1,271,093 shares
|
— | 30 Sep 2025 |
| Prosight Management, LP |
13F
Company
|
1.2%
|
$4,133,566
1,267,965 shares
|
— | 30 Sep 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
0.97%
|
$3,461,000
1,061,295 shares
|
— | 30 Sep 2025 |
| Qube Research & Technologies Ltd |
13F
Company
|
0.93%
|
$3,306,807
1,014,358 shares
|
— | 30 Sep 2025 |
| AQR CAPITAL MANAGEMENT LLC |
13F
Company
|
0.8%
|
$2,846,787
873,247 shares
|
— | 30 Sep 2025 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
0.78%
|
$2,771,000
850,000 shares
|
— | 30 Sep 2025 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
0.68%
|
$2,425,681
744,074 shares
|
— | 30 Sep 2025 |
| NORTHERN TRUST CORP |
13F
Company
|
0.6%
|
$2,141,863
657,013 shares
|
— | 30 Sep 2025 |
| FEDERATED HERMES, INC. |
13F
Company
|
0.57%
|
$2,045,868
627,567 shares
|
— | 30 Sep 2025 |
| ADAR1 Capital Management, LLC |
13F
Company
|
0.53%
|
$1,877,108
575,800 shares
|
— | 30 Sep 2025 |
| DIMENSIONAL FUND ADVISORS LP |
13F
Company
|
0.51%
|
$1,812,003
555,823 shares
|
— | 30 Sep 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.47%
|
$1,678,643
514,921 shares
|
— | 30 Sep 2025 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.44%
|
$1,579,408
484,481 shares
|
— | 30 Sep 2025 |
| Squarepoint Ops LLC |
13F
Company
|
0.4%
|
$1,429,116
438,379 shares
|
— | 30 Sep 2025 |
| Susquehanna Portfolio Strategies, LLC |
13F
Company
|
0.4%
|
$1,416,173
434,409 shares
|
— | 30 Sep 2025 |
| Privium Fund Management B.V. |
13F
Company
|
0.4%
|
$1,410,798
432,760 shares
|
— | 30 Sep 2025 |
| M28 Capital Management LP |
13F
Company
|
0.35%
|
$1,257,317
385,680 shares
|
— | 30 Sep 2025 |
| BNP PARIBAS FINANCIAL MARKETS |
13F
Company
|
0.35%
|
$1,230,924
377,584 shares
|
— | 30 Sep 2025 |
| FMR LLC |
13F
Company
|
0.29%
|
$1,016,147
311,701 shares
|
— | 30 Sep 2025 |
| Hennion & Walsh Asset Management, Inc. |
13F
Company
|
0.28%
|
$995,728
305,438 shares
|
— | 30 Sep 2025 |
| Voss Capital, LP |
13F
Company
|
0.27%
|
$978,000
300,000 shares
|
— | 30 Sep 2025 |
| ROYAL BANK OF CANADA |
13F
Company
|
0.26%
|
$915,000
280,708 shares
|
— | 30 Sep 2025 |
| PDT Partners, LLC |
13F
Company
|
0.24%
|
$867,101
265,982 shares
|
— | 30 Sep 2025 |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
Company
|
0.24%
|
$862,045
264,431 shares
|
— | 30 Sep 2025 |
| Bank of New York Mellon Corp |
13F
Company
|
0.22%
|
$799,721
245,313 shares
|
— | 30 Sep 2025 |
| ExodusPoint Capital Management, LP |
13F
Company
|
0.22%
|
$789,520
242,184 shares
|
— | 30 Sep 2025 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
0.21%
|
$731,000
224,276 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
183
Shares
91,180,049
Rows loaded
183
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
171
Q4 2025 holders
183
Holder diff
12
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.